VSIR and pancreatic neoplasm: Recently, Hou et al. proved that in pancreatic cancer, VISTA expression on tumor cells could be correlated with prolonged overall survival, and anti-VISTA antibody treatment significantly reduced the number of metastatic nodules [85].